NIH-funded research R01 grant

Endothelial inflammation and plaque healing in atherosclerosis

Official title: Inflammation-resolution programs in endothelial cells in atherosclerosis

Funded at Albany Medical College · NIH-11376620 · Data updated 2026-11-12

This research aims to understand how the lining of blood vessels can resolve inflammation to help prevent or repair heart disease in people already taking cholesterol-lowering medicines.

More Atherosclerosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startJune 5, 2026
Project endFebruary 29, 2028
Funding year2026
Award (this year)$1,634,428
NIH project number1R01HL180483-01A1
Project IDNIH-11376620 on NIH RePORTER

Who could benefit from this research

Could help

People with atherosclerosis or at high risk who are receiving cholesterol-lowering treatment may be eligible to benefit from future therapies arising from this work.

Less likely to help

Patients without atherosclerosis or those not pursuing therapies arising from this research may not directly benefit.

What this research studies

Researchers at Albany Medical College will study how endothelial cells (the inner lining of arteries) control inflammation during atherosclerosis, especially when patients are on statins or other cholesterol treatments. They will look at signals that turn off inflammation and promote healing, including SOCS3 and molecules that resolve inflammation. The study uses laboratory experiments to map how these signals influence plaque stability and repair. The goal is to uncover new ways to boost the body’s natural ability to resolve vascular inflammation and reduce cardiovascular risk.

Why it matters

Potential benefit: If successful, the work could reveal new targets to enhance inflammation resolution and stabilize plaques, potentially lowering cardiovascular events in patients on cholesterol-lowering therapies.

How similar studies have gone: Previous studies have shown that modulating inflammatory signals can influence plaque stability, supporting potential benefits of this approach in humans.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Fredman, Gabrielle — Albany Medical College
  • Study coordinator: Fredman, Gabrielle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.